Skip to content
This website uses cookies to help us understand the way visitors use our website. We can't identify you with them and we don't share the data with anyone else. If you click Reject we will set a single cookie to remember your preference. Find out more in our privacy policy.

AHSN-supported QbTest helps improve ADHD diagnosis in children and young people

26 October 2021
The AHSN Network – including UCLPartners - is helping to transform Attention Deficit Hyperactivity Disorder (ADHD) services across England with the rollout of technology that can provide an objective assessment and help families to receive a diagnosis more quickly.

New figures released during ADHD Awareness Month (October) show that, since the start of the first ‘demonstrator’ site in the East Midlands in 2017, 52,000 children across England have had an objective assessment for ADHD using the QbTest technology.

The QbTest has a strong evidence base that shows direct benefits for the patient, their family as well as the wider healthcare system. QbTest measures core ADHD symptoms: activity, attention and impulsivity. A typical test lasts no more than 15-20 minutes. The test results are instantly analysed and presented in a report that compares a patient’s results with a group of people of the same age and gender who do not have ADHD.

Following the real-world demonstrator project commissioned by East Midlands AHSN in 2017, the team is leading the national Focus ADHD programme across all 15 AHSNs to roll the test out across the country. As an AHSN UCLPartners is helping to roll out QbTest across our region, as part of our priority to improve children’s and young people’s mental health.

Despite Covid restrictions, nearly 10,000 children benefited from undertaking a QbTest in 2020/21. A further 9,500 tests have been completed by the end of September 2021 at 51 trusts across 100 sites.  

To find out more visit